宋咪咪,韩吉祥

本研究旨在探讨心脏代谢指数（Cardiac Metabolic Index，CMI）、预估葡萄糖处理率（Estimated Glucose Disposal Rate，eGDR）与血清脂蛋白a（Lp(a)）在合并缺血性脑卒中的2型糖尿病（T2DM）患者中的关联性。随着每年T2DM发病率的上升，其并发症之一的缺血性脑卒中已成为显著的公共健康问题，严重影响患者的生活质量及生存率。CMI、eGDR、Lp(a)作为潜在生物标志物，可能在评估T2DM患者的脑卒中风险方面发挥重要作用。通过对这些生物标志物的研究，可以更深入地理解其在心血管代谢异常及脑卒中发生中的作用机制，并为临床干预策略的制定提供理论依据与实践指导。

心脏代谢指数；预估葡萄糖处理率；血清脂蛋白a；2型糖尿病；缺血性脑卒中

[1] Si S,Li J,Li Y,et al.Causal Effect of the Triglyceride-Glucose Index and the Joint Exposure of Higher Glucose and Triglyceride With Extensive Cardio-Cerebrovascular Metabolic Outcomes in the UK Biobank:A Mendelian Randomization Study.Front Cardiovasc Med.7:583473.Published 2020. [2] Choi EJ,Lee SY.Index of Cardiac Age Index and Cardiometabolic Biomarkers in Adults with Metabolic Syndrome.Metab Syndr Relat Disord.2021;19(5):288-295. [3] Wibowo PG,Charman SJ,Okwose NC,et al.Association between cardiac high-energy phosphate metabolism and whole body metabolism in healthy female adults.Physiol Res.2021;70(3):393-399. [4] Li MJ,Li CY,Sha MX,Zhang Y,Liu Y.[Study on mechanism of Aconitum pendulum in treating rheumatoid arthritis based on toxicity efficacy evaluation and metabonomics].Zhongguo Zhong Yao Za Zhi.2024;49(7):1774-1784. [5] Wang T,Xu J,Zhang H,Tao L,Huang X.Triglyceride-glucose index for the detection of subclinical heart failure with preserved ejection fraction in patients with type 2 diabetes.Front Cardiovasc Med.10:1086978.Published 2023. [6] Tang X,Shi R,Jiang L,et al.Additive effect of metabolic dysfunction-associated fatty liver disease on left ventricular function and global strain in type 2 diabetes mellitus patients:a 3.0 T cardiac magnetic resonance feature tracking study.Cardiovasc Diabetol.2024; 23(1):317. Published 2024 Aug 27. [7] Zhan QY,Xie LX,Wang C.[Promoting critical care system and capacity building in pulmonary and critical care medicine subspecialties]. Zhonghua Yi Xue Za Zhi.2023;103(40):3149-3151. [8] Wu L,Cheng Y,Wang R,Sun S,Ma B,Zhang Z.NDRG2 regulates glucose metabolism and ferroptosis of OGD/R-treated astrocytes by the Wnt/β-catenin signaling.J Biochem Mol Toxicol.2024;38(9):e23827. [9] Schmitt VH,Billaudelle AM,Schulz A,et al.Disturbed Glucose Metabolism and Left Ventricular Geometry in the General Population.J Clin Med.2021;10(17).Published 2021 Aug 27. [10] Ren Y,Chen B,Zhang H,Xu S.A cohort study reveals shared and distinct serum metabolic biomarkers for major adverse cardiovascular events in middle-aged and older adults.Geroscience..Published online Feb 4,2025. [11] Ham JA,Jeong YJ,Ma MK,Moon HI.The Impact of Cortical Cerebral Microinfarcts on Functional Outcomes in Patients With Ischemic Stroke.Brain Neurorehabil.2022;15(3):e30.Published 2022 Nov. [12] Cernea S,Onișor D,Roiban AL,Benedek T,Rat N.Metabolic dysfunction-associated steatotic liver disease-associated fibrosis and cardiac dysfunction in patients with type 2 diabetes.World J Cardiol.2024;16(10):580-594. [13] Rokicka D,Hudzik B,Wróbel M,et al.The prognostic impact of insulin resistance surrogates in patients with acute myocardial infarction with and without type 2 diabetes.Cardiovasc Diabetol.2024;23(1):147.Published 2024 Apr 29. [14] Youyou Z,Ruirui J,Hui W,Zhaoyang L.Association between lipoprotein(a)and ischemic stroke:Fibrinogen as a mediator.J Neurol Sci.452:120738. [15] Boffa MB,Koschinsky ML.Lipoprotein(a)and cardiovascular disease.Biochem J.2024;481(19):1277-1296. [16] Chen J,Luo Q,Yi Y,et al.ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients.Lipids Health Dis.2024;23(1):356. Published 2024 Nov 1. [17] Tsamoulis D,Kosmas CE,Rallidis LS.Is inverse association between lipoprotein(a)and diabetes mellitus another paradox in cardiometabolic medicine?Expert Rev Endocrinol Metab.2024 Jan-May;19(1):63-70. [18] Huang Y,Zhang R,Han L,et al.Lipoprotein(a)and stroke:a two-sample Mendelian randomization study.Front Aging Neurosci. 15:1178079.Published 2023. [19] Langsted A,Nordestgaard BG,Kamstrup PR.Elevated Lipoprotein(a)and Risk of Ischemic Stroke.J Am Coll Cardiol.2019;74(1):54-66. [20] Cefalo CMA,Riccio A,Fiorentino TV,et al.Impaired insulin sensitivity measured by estimated glucose disposal rate is associated with decreased myocardial mechano-energetic efficiency in non-diabetic individuals.Eur J Intern Med.130:144-150. [21] Kumar R,Chhillar N,Gupta DS,Kaur G,Singhal S,Chauhan T.Cholesterol Homeostasis,Mechanisms of Molecular Pathways,and Cardiac Health:A Current Outlook.Curr Probl Cardiol.2024;49(1 Pt B):102081. [22] Heinisch PP,Mihalj M,Huber M,et al.Impact of Lipoprotein(a)Levels on Perioperative Outcomes in Cardiac Surgery.Cells. 2021;10(11). Published 2021 Oct 21. [23] Lu Q,Lu J,Li C,et al.Cardiopulmonary Exercise Testing-Guided Exercise Therapy in Hypertensive Patients:A Single Center Study. Cardiovasc Ther.2024:8476971.Published 2024. [24] Ogieuhi IJ,Callender K,Odukudu GO,et al.Antisense Oligonucleotides in Dyslipidemia Management:A Review of Clinical Trials.High Blood Press Cardiovasc Prev.2025;32(1):33-47. [25] Ansari S,Neely RDG,Payne J,Cegla J.Lipoprotein(a)testing in lipid clinics across the UK:Results of a national survey.J Clin Lipidol. 2024 May-Jun;18(3):e477-e481.

点击下载PDF